Insider Confidence Is Surging at Alumis

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

📌 Alumis $ALMS — CEO Srinivas Akkaraju bought $1.31 Million, revealed by a new Form 4.

A meaningful biotech purchase from a top operator. Size stands out in the space and adds conviction as the stock continues to carve out a deep IPO base.

📌 Johnson & Johnson $JNJ — Director John Morikis bought $258,000 per a new Form 4.

A rare insider buy at a mega-cap healthcare bellwether. Small relative to its size, but seeing a director step in at all-time highs is telling.

Here’s The Hot Corner, with data from December 1, 2025:

📌 Baldwin Insurance Group $BWIN — William Blair IM boosted its 13G stake from 4.31% to 10.9%.

An aggressive increase — nearly tripling ownership. A strong institutional vote of confidence in a name that’s halved since its highs over a year ago. 

📌 Ashland $ASH — Standard Investments filed a new 13D at 5.7%.

A timely purchase as the stock jets higher off a key level of support, failing to complete a near decade-long distribution pattern.